This saga is a classic slow motion train wreck. With the wisdom of hindsight I would guess we left the rails at the time BSI changed their classification. But management at that time thought we could get back on the track. However, that's history and cannot be changed. The key problem was a CEO who would not listen and too fond of shortcuts. He's gone, along with the chairman. I believe the remaining team are capable of flourishing now that they are operating out of the shadows of previous management, and deserve our support.
Here's hoping they keep up the information flow and PLEASE sort out the IP question - it cannot be hard to transfer all across to TIS and remove this uncertainty.
Fingers crossed that there remains some space in the wound healing market for when this good product finally gets there.
The sp must surely have bottomed!?
TIS Price at posting:
5.1¢ Sentiment: Hold Disclosure: Held
